By recruiting HDAC1, MORC2 suppresses p21 Waf1/Cip1 in gastric cancer

Qing Zhang; Yanyan Song; Wei Chen; Xiaohui Wang; Zhifeng Miao; Liu Cao; Feng Li; Guiling Wang

doi:10.18632/oncotarget.3889

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

By recruiting HDAC1, MORC2 suppresses p21 Waf1/Cip1 in gastric cancer

Qing Zhang _, Yanyan Song, Wei Chen, Xiaohui Wang, Zhifeng Miao, Liu Cao, Feng Li and Guiling Wang

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2015; 6:16461-16470. https://doi.org/10.18632/oncotarget.3889

Metrics: PDF 2129 views | HTML 3330 views | ?

Abstract

Qing Zhang1, Yanyan Song1, Wei Chen1, Xiaohui Wang1, Zhifeng Miao2, Liu Cao1, Feng Li1, Guiling Wang1

1Department of Cell Biology, Key Laboratory of Cell Biology, Ministry of Public Health, and Key Laboratory of Medical Cell Biology, Ministry of Education, China Medical University, Shenyang, China

2Department of Surgical Oncology and General Surgery, First Hospital of China Medical University, Shenyang, China

Correspondence to:

Guiling Wang, e-mail: [email protected]

Feng Li, e-mail: [email protected]

Keywords: MORC2, p21, HDAC1, cell proliferation, gastric cancer

Received: January 21, 2015 Accepted: April 25, 2015 Published: May 08, 2015

ABSTRACT

Microrchidia (MORC) family CW-type zinc-finger 2 (MORC2) regulates chromatin remodeling during the DNA-damage response, represses gene transcription, promotes lipogenesis. Here, we found that MORC2 down-regulated p21 by recruiting HDAC1 to the p21 promoter, in a p53-independent manner. MORC2-mediated down-regulation of p21 in turn promoted cell cycle progression in gastric cancer cells. Furthermore, MORC2 expression correlated negatively with p21 expression in gastric tumors in patients. We suggest that MORC2 may be a potential therapeutic target in cancer.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 3889

Publication Alerts

Post-Publication Promotion

Publication Discount

Research Papers:

By recruiting HDAC1, MORC2 suppresses p21 Waf1/Cip1 in gastric cancer

Abstract